Endothelial function and its assessment

被引:38
作者
Felmeden, DC [1 ]
Lip, GYH [1 ]
机构
[1] Univ Birmingham, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, City Hosp, Birmingham, W Midlands, England
关键词
assessment; cilatation; endothelial function; flow mediated;
D O I
10.1517/13543784.14.11.1319
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endothelial dysfunction is a characteristic aspect of most of the conditions associated with atherosclerosis and is commonly found as an early feature in atherothrombotic vascular disease. An appreciation of the underlying mechanisms of endothelial function, as well as dysfunction, is essential as this has critical influence on the different methods in the assessment of endothelial function and effects of various treatments on its quantification. Furthermore, endothelial dysfunction is recognised as a type of 'target organ damage' in common cardiovascular conditions (e.g., hypertension) and the area is of increasing interest for new drug development, as therapies that modulate the endothelium will have added advantages; thus, for the development of new/experimental drugs, an awareness of ways to assess the endothelium is necessary. In this review, an overview of different methods including biochemical markers, and invasive and non-invasive tools, to determine endothelial function is presented as well as their clinical relevance. Furthermore, the effects of various treatments on endothelial dysfunction and their underlying mechanisms are elucidated.
引用
收藏
页码:1319 / 1336
页数:18
相关论文
共 245 条
  • [11] Circulating cell adhesion molecules and death in patients with coronary artery disease
    Blankenberg, S
    Rupprecht, HJ
    Bickel, C
    Peetz, D
    Hafner, G
    Tiret, L
    Meyer, J
    [J]. CIRCULATION, 2001, 104 (12) : 1336 - 1342
  • [12] BLANN A, 1993, BRIT J BIOMED SCI, V50, P125
  • [13] Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
    Blann, AD
    Waite, MA
    [J]. CORONARY ARTERY DISEASE, 1996, 7 (02) : 143 - 147
  • [14] Circulating endothelial cells - Biomarker of vascular disease
    Blann, AD
    Woywodt, A
    Bertolini, F
    Bull, TM
    Buyon, JP
    Clancy, RM
    Haubitz, M
    Hebbel, RP
    Lip, GYH
    Mancuso, P
    Sampol, J
    Solovey, A
    Dignat-George, F
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 93 (02) : 228 - 235
  • [15] BLANN AD, 1994, J HYPERTENS, V12, P925
  • [16] The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications
    Blann, AD
    Yip, GYH
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 297 - 306
  • [17] A RELIABLE MARKER OF ENDOTHELIAL-CELL DYSFUNCTION - DOES IT EXIST
    BLANN, AD
    TABERNER, DA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) : 244 - 248
  • [18] BOBIK A, 1993, PHARMACOL REV, V45, P1
  • [19] GROWTH-FACTOR ACTIVITY OF ENDOTHELIN ON VASCULAR SMOOTH-MUSCLE
    BOBIK, A
    GROOMS, A
    MILLAR, JA
    MITCHELL, A
    GRINPUKEL, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03): : C408 - C415
  • [20] Boger RH, 1996, CLIN EXP PHARMACOL P, V23, P11